Insights drawing from historical metrics that optimize pre- and post-commercialization marketing efforts for new therapies
Before going to market with a new drug, medical device, or test, it’s crucial to know how payers will treat it. Understanding coverage restrictions, as well as knowing what's likely to happen in the first six months to two years before commercialization, allows organizations to design effective marketing strategies.
Drew Gutschmidt, president, Policy Reporter, a TrialCard company and Scott Dulitz, chief strategy officer and head of corporate development, TrialCard, discuss the importance of their predictive payer offering.
Offered Free by: Trialcard
See All Resources from: Trialcard